Clinical Trials Update: Feb. 2, 2007
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
90104
A report to be released on Friday finds the U.S. Food and Drug Administration does very little to ensure the safety of patients who help test drugs in clinical trials, The New York Times reports.
527274
roundup Plus: PMC-Sierra lowers forecast...WebSideStory cuts IPO to 4.4 million shares...BMC looks to simplify network operations.
240625
Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
511748
Northfield announces clinical trial results that investors can learn from.
225429
2007 top science developments, tech flops, and vaporware...Szulik's parting words as Red Hat CEO...Sony Alpha A700 review...copyright tidbits...Toshiba 32nm deal with IBM
367540
WEDNESDAY, Dec. 8 (HealthDayNews) -- Two separate studies offer some good news about two drugs for the treatment of Parkinson's disease.
283297
Researchers at Merck can use neural stem-cell tech in early stages of drug development. Plus: Pay for eggs OK in Britain. In Bodyhack.
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
734839
Neurocrine resubmits a marketing application for its lead drug.
563594
The Kootenai Medical Center's North Idaho Cancer Center will begin offering some patients the option of taking part in trials of experimental cancer drugs, starting in January.
362077
Clinical trial data released by pharmaceutical company Boehringer Ingelheim at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, DC, on its experimental protease inhibitor tipranavir show that the drug is effective
98672
At the International Diabetes Federation meeting in Los Angeles, USA, it will be announced today that a larger clinical trial with Diamyd will start in type 2 diabetes patients in Sweden.
388102
Pre-clinical trial results are mixed, but mark a major step forward for developing human treatments.
303689
Acorda announces positive clinical trial data.
662969
Les donnÃ©es indiquent une augmentation de la rÃ©ponse sÃ©rologique, virologique et biochimique aprÃ¨s 144 semaines de traitement sur des patients naÃ¯fs atteints de l&#39;hÃ©patite B antigÃ¨ne positif.
414089
A website goes the extra mile to make sure voters aren & rsquo;t confused this Tuesday.  Also: West Virginia organizes the first public supercomputer & hellip;.  FDA keeps its eye on a new pain relief drug & hellip;. and more.